Results 261 to 270 of about 878,879 (388)

A Pragmatic Approach to Improving Management and Patient Flow for Painful Diabetic Neuropathy in UK Primary Care. [PDF]

Diabetes Ther
Fernando K, Bell H, Davies S, Holmes P, Kelly B, Seidu S.   +5 more
europepmc   +1 more source

Amelioration of Diabetic Neuropathy by TAT-Mediated Enhanced Delivery of Metallothionein and SOD [PDF]

, 2011
Dongsoo Min, Hyunok Kim, Leejin Park, Tae Hwa Kim, Se Jin Hwang, Mi Jung Kim, Seong‐Ho Jang, Yongsoo Park   +7 more
openalex   +1 more source

Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Objective We aim to compare second‐generation automated insulin delivery systems (AIDs) with other treatment modalities regarding both glucose management outcomes and person‐reported outcomes/experiences (PROs/PREs, measured by the Hypoglycemia Fear Survey, Hypoglycemic Confidence Scale, Hyperglycemia Avoidance Scale, Diabetes Distress Scale ...
Zekai Wu, Laure Alexandre‐Heymann, Maha Lebbar, Meryem K. Talbo, Aude Bandini, Tamanna Chahal, Caroline Grou, Virginie Messier, Valérie Boudreau, Anne‐Sophie Brazeau, Rémi Rabasa‐Lhoret   +10 more
wiley   +1 more source

Circ_0000756 Mediates Oxidative Stress and Metabolic Memory in Diabetic Neuropathy via miR-7b Suppression of NRF2/ARE Pathway. [PDF]

FASEB J
Chen J, Lu Y, Chen Y, Liu X, Chen W, Zhao P, Yang F.   +6 more
europepmc   +1 more source

Barriers and new opportunities in developing effective therapies for diabetic neuropathy: International expert consensus recommendations

Christina Brock, Henning Andersen, Amra Ciric Alibegovic, S ren Due Andersen, Lars Vibe Andreasen, Morten Charles, Diana Hedevang Christensen, AM Drewes, M.-A. Gall, Sandra Sif Gylfadottir, Christian Stevns Hansen, S K Hecquet, Troels S. Jensen, Páll Karlsson, Lisbet Knudsen, Cirley Lobato, Huda Kufaishi, Haïfa Maalmi, H I Mizrak, Kristian Bernhard Nilsen, Ba Perkins, Johan Røikjer, Peter Rossing, Joergen Rungby, John Rømer, Anders Stouge, Karolina Sulek, Eirik Søfteland, Abd A. Tahrani, Astrid Juhl Terkelsen, Solomon Tesfaye, Anne‐Marie Wegeberg, Thorbjörn Åkerström, Birgitte Brock, Rodica Pop‐Busui   +34 more
openalex   +1 more source

Diabetic Peripheral Neuropathy: Epidemiology, Diagnosis, and Pharmacotherapy.

Clinical Therapeutics, 2018
Zohaib Iqbal, S. Azmi, R. Yadav, M. Ferdousi, M. Kumar, D. Cuthbertson, Jonathan Lim, R. Malik, U. Alam   +8 more
semanticscholar   +1 more source

A nationwide 12‐month observatory of automated insulin delivery shows improved glucose control, sustained adoption, and reduced acute severe events

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims A nationwide observational study was conducted to assess the 12‐month effectiveness of AID systems in the routine care of people with Type 1 diabetes (PwT1D). Methods All PwT1D, adults, and children, who initiated AID between January 1, 2022, and December 31, 2022, were included across 79 centres.
Jean‐Pierre Riveline, Jean‐Baptiste Julla, Elisabeth Bonnemaison, Michael Joubert, Sandrine Lablanche, Agnès Sola Gazagnes, Delphine Demarsy, Didier Gouet, Pauline Schaepelynck, Chloé Amouyal, Fabienne Dalla Vale, Anne Schletzer‐Mari, Sylvaine Clavel, Anne Spiteri, Catherine Campinos, Sandrine Favre, Igor Tauveron, Laurence Mathivon, Sophie Borot, Guy Fagherazzi, Marc D. Breton, Jean‐François Gautier, Eric Renard, for the OB2F study group, Jean‐Pierre Riveline, Manal Al Masri‐Shbat, Emmanuel Cosson, Isabela Banu, Michael Joubert, Agnès Sola Gazagnes, Gaetan Prevost, Sandrine Lablanche, Pauline Schaepelynck, Charles Thivolet, Nicolas Chevalier, Sophie Borot, Bruno Guerci, Elise Bismuth, Jacques Beltrand, Delphine Demarsy, Emmanuelle Bourrinet, Didier Gouet, Lucien Marchand, Louis Gerbaud‐Morlaes, Salha Fendri, Sylvaine Clavel, René Valero, Emmanuel Sonnet, Blandine Delenne, Jean‐Paul Donnet, Emma Carreira, Cedric Fagour, Camille Vatier, Rosine Guintrand, Luc Rakotoarisoa, Aurélie Carlier, Anne Spiteri, Igor Tauveron, Lemoine Amal, Letitia Pantalone, Anne Schletzer, Karen Berthelon, Natacha Germain, Françoise Latil Plat, Aroua Temessek, Marie Mansilla, Lorraine Thomesse, Fabienne Dalla Valle, Anne‐Cécile Paepegaey, Nadège Bachere, Candace Ben Signor, Samy Hadjadj, Thanh Lan Dangduy, Mathieu Giraud, Sandrine Favre, Joëlle Dupont, Anna Flaus Furmaniuk, Laure Houdon Nguyen, Patricia Pigeon Kherkiche, Anne‐Cécile Gauthier, Anne Vambergue, Alina Radu, Sandra Pochelu, Abine Baron, Chloé Amouyal, Jennifer Allain‐Cohen, Mariana Geamanu, Florent Verdier, Yannis Chartier, Nathalie Garrec, Annie Sfez, laurence Mathivon, Christine Rouby, Emeline Renard, Agnès Tamboura, Leïla Mchirgui, PH Emilie Georget, Elise Pinto da Rocha, Laure Oilleau‐Barral   +98 more
wiley   +1 more source

Diabetic Neuropathy [PDF]

Diabetes, 1956
openaire   +2 more sources

Hyperpolarization-activated cyclic nucleotide–gated 2 (HCN2) ion channels drive pain in mouse models of diabetic neuropathy

Science Translational Medicine, 2017
C. Tsantoulas, S. Laínez, Sara Wong, I. Mehta, Bruno Vilar, P. McNaughton   +5 more
semanticscholar   +1 more source

Efficacy and safety of bi‐weekly cofrogliptin treatment replacing daily dipeptidyl peptidase‐4 inhibitors in Chinese patients with type 2 diabetes mellitus: A multicenter, open‐label, randomized controlled phase 2 trial

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study aimed to investigate the efficacy and safety of bi‐weekly cofrogliptin treatment as a replacement for daily dipeptidyl peptidase‐4 inhibitors (DPP‐4is) in Chinese patients with type 2 diabetes mellitus (T2DM). Methods This multicenter, open‐label, randomized controlled study assigned participants in a 1:1 ratio to either the ...
Congqing Pan, Hongwei Jiang, Yi Feng, Suijun Wang, Jin Zhang, Zhongjing Wang, Yusen Zhou, Fangqiong Li, Zhanhui Zhang, Yaming Li, Liming Chen   +10 more
wiley   +1 more source